#semaglutide
Related Stories (10)
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial - reuters.com
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial reuters.com
September 30, 2026Novo Nordisk says semaglutide cut obesity rates in young children in trial - Reuters
Novo Nordisk says semaglutide cut obesity rates in young children in trial Reuters
September 7, 2026Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump - Reuters
Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump Reuters
August 20, 2026Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case - Reuters
Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case Reuters
August 5, 2026India's Dr Reddy's warns of wider semaglutide supply impact after profit miss - Reuters
India's Dr Reddy's warns of wider semaglutide supply impact after profit miss Reuters
July 22, 2026India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice - Reuters
India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice Reuters
July 9, 2026India's Dr Reddy's delays semaglutide supply, loses $678 mln in market value - Reuters
India's Dr Reddy's delays semaglutide supply, loses $678 mln in market value Reuters
July 9, 2026Weight-loss drug Wegovy to be available in pill form in UK for first time
Manufacturer Novo Nordisk says a daily tablet of the drug could be more convenient for some people than weekly injections.
June 11, 2026India's cheap weight-loss drugs could reshape global obesity fight
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
March 18, 2026Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say - Reuters
Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say Reuters
February 25, 2026Related Pages (12)
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Weight-loss drug Wegovy to be available in pill form in UK for first time
A pill version of the blockbuster weight-loss drug Wegovy has been approved in the UK, meaning people will soon be able to buy it with a prescription. It is the first tablet of its kind to get cleare
India's cheap weight-loss drugs could reshape global obesity fight
India could soon get a lot thinner - at least in theory. On Friday the patent on semaglutide - the molecule behind Danish drugmaker Novo Nordisk's blockbuster weight-loss drugs Wegovy and Ozempic - e
Dr Reddy's files 'Obeda' trademark ahead of generic ozempic launch
Hyderabad-based Dr Reddy’s Laboratories has applied to trademark the brand name and logo “Obeda”, according to sources. The proposed brand is expected to be the company’s version of semaglutide, the
Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say
Listen to this article in summarized format Unlock AI Briefing and Premium Content (Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.) Subscribe to The Econo
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa